These data suggest that CXCL12 specifically alters the ability of pancreatic cancer cells to home to the liver, an organ with high expression of CXCL12 and a common metastatic destination of PDAC patients. This evidence concerns the gene CXCL12 and familial pancreatic carcinoma.